Key Takeaways
- PLTR shares advanced 2.3% in pre-market hours to $131.05 on Monday, April 13.
- President Trump highlighted the company’s defense capabilities on Truth Social, describing it as an effective “war fighting” platform.
- ARK Invest acquired 85,485 PLTR shares distributed across five exchange-traded funds, totaling approximately $10.95–$11.15 million.
- ARKK ETF accounted for the largest portion with 46,455 shares, while ARKQ, ARKW, ARKF, and ARKX also increased their holdings.
- Year-to-date, PLTR has declined 28% in 2026 and currently trades at 99 times projected 2026 earnings.
Palantir shares experienced a pre-market boost Monday courtesy of dual catalysts: presidential recognition and significant institutional buying from Cathie Wood’s investment firm.
The equity climbed 2.3% before the opening bell, reaching $131.05 during early trading. This upward movement occurred while broader market indices struggled — S&P 500 futures declined 0.6% as Trump’s directive ordering the U.S. Navy to establish a blockade in the Strait of Hormuz created investor uncertainty.
Palantir Technologies Inc., PLTR
Trump took to Truth Social on Friday with this message: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!” The statement provided support for PLTR during a trading session already challenged by investor concerns surrounding Anthropic’s newest AI model release.
Presidential commentary has influenced the stock’s trajectory before, establishing a recurring pattern that market watchers have come to recognize.
Cathie Wood’s Firm Accumulates Significant Position
The April 11 daily trade report from ARK Invest revealed the firm acquired 85,485 Palantir shares spread across five different ETF vehicles. The aggregate investment ranged between $10.95 million and $11.15 million based on varying price calculations.
ARKK ETF led the buying activity with 46,455 shares. Additional purchases included 15,127 shares in ARKQ, 11,865 shares in ARKW, 5,973 shares in ARKF, and 6,065 shares in ARKX.
Wood has maintained a bullish stance on Palantir for an extended period. Given the stock’s substantial retreat from peak levels, this transaction appears to represent ARK capitalizing on reduced valuations to expand an established high-conviction holding.
Meanwhile, ARK divested 44,446 AMD shares valued at approximately $10.52 million across identical ETFs. The firm also liquidated 75,389 shares of Strata Critical Medical (SRTA) for roughly $305,000, maintaining its ongoing exit strategy from that holding.
Valuation Challenges Persist
Despite favorable news flow, Palantir[[/LINK_END_3]] faces significant headwinds through 2026. Year-to-date performance shows a 28% decline, representing a substantial pullback from late 2025 peak levels.

